Absci is using its AI-driven discovery platform to design antibodies against “unaddressable” targets (GPCRs, ion channels, difficult-to-agonize targets), citing its Origin-1 model’s ability to ...

Eli Lilly advances CRISPR collaboration with Scribe Therapeutics for neurological and neuromuscular disorders; European ...

The FDA granted the approval following findings from the pivotal POETYK PsA-I and POETYK PsA-II Phase III studies.

A Body to Live In’ a fascinating trip into a transgressive culture ...

Excited for NASA's Artemis II launch? The best model rockets mean you can have your own rocket launch, as scale replicas and STEM kits all feature. When you purchase through links on our site, we may ...

Microneedling may stimulate hair growth when combined with topical hair loss treatments. The treatment can improve blood circulation and increase collagen production. Derma rollers can be used at home ...

Phase II study tested combination of sacituzumab govitecan plus pembrolizumab ...

TD Cowen 46th Annual Health Care Conference March 2, 2026 9:10 AM ESTCompany ParticipantsSean McClain - Founder, CEO, ...

A cornerstone of the platform is a fixed-price model. Lilly is offering the Zepbound KwikPen to network pharmacies at a discounted rate of $449 for all dosages. The final cost to patients will still ...